Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin’s T5-loop-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin’s T5-loop

Published:2024-06 Issue:6 Volume:300 Page:107363
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Abel Anne-Catherine^ORCID,Mühlethaler Tobias,Dessin Cedric,Schachtsiek Thomas,Sammet Benedikt,Sharpe Timothy,Steinmetz Michel O.^ORCID,Sewald Norbert^ORCID,Prota Andrea E.^ORCID

Funder

European Commission

Bielefeld University

Paul Scherrer Institute

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Elsevier BV

Reference37 articles.

1. Global Cancer Observatory: Cancer Today International Agency for Reserach on Cancer;Ferlay,2020

2. Cancer Trends Progress Report - Life After Diagnosis - Financial Burden of Cancer Care,2021

3. Global Cancer Observatory: Cancer Tomorrow International Agency for Reserach on Cancer;Ferlay,2020

4. Structure determination, conformational analysis, chemical stability studies, and antitumor evaluation of the cryptophycins. Isolation of 18 new analogs from Nostoc sp. strain GSV 224;Golakoti;J. Am. Chem. Soc.,1995

5. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells;Smith;Cancer Res.,1994

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development;Marine Drugs;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP